Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Ayurvedic genomics, constitutional psychology, and endocrinology: the missing connection.

Rizzo-Sierra CV.

J Altern Complement Med. 2011 May;17(5):465-8. doi: 10.1089/acm.2010.0412. Epub 2011 May 12.

PMID:
21563964
2.

Potential role of metabolomics apporoaches in the area of traditional Chinese medicine: as pillars of the bridge between Chinese and Western medicine.

Wang X, Sun H, Zhang A, Sun W, Wang P, Wang Z.

J Pharm Biomed Anal. 2011 Jul 15;55(5):859-68. doi: 10.1016/j.jpba.2011.01.042. Epub 2011 Feb 26. Review.

PMID:
21353755
3.

Effects of a restricted elimination diet on the behaviour of children with attention-deficit hyperactivity disorder (INCA study): a randomised controlled trial.

Pelsser LM, Frankena K, Toorman J, Savelkoul HF, Dubois AE, Pereira RR, Haagen TA, Rommelse NN, Buitelaar JK.

Lancet. 2011 Feb 5;377(9764):494-503. doi: 10.1016/S0140-6736(10)62227-1.

PMID:
21296237
4.

Metabolomics: towards understanding traditional Chinese medicine.

Zhang A, Sun H, Wang Z, Sun W, Wang P, Wang X.

Planta Med. 2010 Dec;76(17):2026-35. doi: 10.1055/s-0030-1250542. Epub 2010 Nov 5. Review.

PMID:
21058239
5.

Systems biology-based diagnostic principles as pillars of the bridge between Chinese and Western medicine.

van der Greef J, van Wietmarschen H, Schroën J, Wang M, Hankemeier T, Xu G.

Planta Med. 2010 Dec;76(17):2036-47. doi: 10.1055/s-0030-1250450. Epub 2010 Oct 26. Review.

PMID:
20979015
6.

Genetic and epigenetic heterogeneity in cancer: the ultimate challenge for drug therapy.

Heng HH, Liu G, Stevens JB, Bremer SW, Ye KJ, Ye CJ.

Curr Drug Targets. 2010 Oct;11(10):1304-16. Review.

PMID:
20840073
7.

The Validus Medicus and a new gold standard.

Ziliak ST.

Lancet. 2010 Jul 31;376(9738):324-5. No abstract available.

PMID:
20681063
8.

Group analysis versus individual response: the inferential limits of randomized controlled trials.

Kelley JM, Kaptchuk TJ.

Contemp Clin Trials. 2010 Sep;31(5):423-8. doi: 10.1016/j.cct.2010.07.003. Epub 2010 Jul 16.

9.

Genetic heterogeneity in human disease.

McClellan J, King MC.

Cell. 2010 Apr 16;141(2):210-7. doi: 10.1016/j.cell.2010.03.032.

10.

The evolutionary mechanism of cancer.

Heng HH, Stevens JB, Bremer SW, Ye KJ, Liu G, Ye CJ.

J Cell Biochem. 2010 Apr 15;109(6):1072-84. doi: 10.1002/jcb.22497. Review.

PMID:
20213744
11.

Beyond genome-wide association studies: genetic heterogeneity and individual predisposition to cancer.

Galvan A, Ioannidis JP, Dragani TA.

Trends Genet. 2010 Mar;26(3):132-41. doi: 10.1016/j.tig.2009.12.008. Epub 2010 Jan 26. Review.

12.

Systems biology guided by Chinese medicine reveals new markers for sub-typing rheumatoid arthritis patients.

van Wietmarschen H, Yuan K, Lu C, Gao P, Wang J, Xiao C, Yan X, Wang M, Schroën J, Lu A, Xu G, van der Greef J.

J Clin Rheumatol. 2009 Oct;15(7):330-7. doi: 10.1097/RHU.0b013e3181ba3926.

PMID:
20009967
13.

Heterogeneity is not always noise: lessons from improvement.

Davidoff F.

JAMA. 2009 Dec 16;302(23):2580-6. doi: 10.1001/jama.2009.1845.

PMID:
20009058
14.

Copy number variation influences gene expression and metabolic traits in mice.

Orozco LD, Cokus SJ, Ghazalpour A, Ingram-Drake L, Wang S, van Nas A, Che N, Araujo JA, Pellegrini M, Lusis AJ.

Hum Mol Genet. 2009 Nov 1;18(21):4118-29. doi: 10.1093/hmg/ddp360. Epub 2009 Jul 31.

15.

Sequence and structural variation in a human genome uncovered by short-read, massively parallel ligation sequencing using two-base encoding.

McKernan KJ, Peckham HE, Costa GL, McLaughlin SF, Fu Y, Tsung EF, Clouser CR, Duncan C, Ichikawa JK, Lee CC, Zhang Z, Ranade SS, Dimalanta ET, Hyland FC, Sokolsky TD, Zhang L, Sheridan A, Fu H, Hendrickson CL, Li B, Kotler L, Stuart JR, Malek JA, Manning JM, Antipova AA, Perez DS, Moore MP, Hayashibara KC, Lyons MR, Beaudoin RE, Coleman BE, Laptewicz MW, Sannicandro AE, Rhodes MD, Gottimukkala RK, Yang S, Bafna V, Bashir A, MacBride A, Alkan C, Kidd JM, Eichler EE, Reese MG, De La Vega FM, Blanchard AP.

Genome Res. 2009 Sep;19(9):1527-41. doi: 10.1101/gr.091868.109. Epub 2009 Jun 22.

16.

Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective.

Heng HH, Bremer SW, Stevens JB, Ye KJ, Liu G, Ye CJ.

J Cell Physiol. 2009 Sep;220(3):538-47. doi: 10.1002/jcp.21799. Review.

PMID:
19441078
17.

Mea Culpa with cancer-targeted therapy: new thinking and new agents design for novel, causal networks-based, personalized biomedicine.

Roukos DH.

Expert Rev Mol Diagn. 2009 Apr;9(3):217-21. doi: 10.1586/erm.09.7. No abstract available.

PMID:
19379079
18.

Phylogenetic modeling of heterogeneous gene-expression microarray data from cancerous specimens.

Abu-Asab MS, Chaouchi M, Amri H.

OMICS. 2008 Sep;12(3):183-99. doi: 10.1089/omi.2008.0010.

19.

Evolutionary medicine: A meaningful connection between omics, disease, and treatment.

Abu-Asab M, Chaouchi M, Amri H.

Proteomics Clin Appl. 2008 Feb;2(2):122-134.

20.

Direct maximum parsimony phylogeny reconstruction from genotype data.

Sridhar S, Lam F, Blelloch GE, Ravi R, Schwartz R.

BMC Bioinformatics. 2007 Dec 5;8:472.

Supplemental Content

Support Center